Neuronetics, Inc. (STIM)

USD 3.79

(0.4%)

Total Assets Summary of Neuronetics, Inc.

  • Neuronetics, Inc.'s latest annual total assets in 2023 was 115.83 Million USD , down -0.9% from previous year.
  • Neuronetics, Inc.'s latest quarterly total assets in 2024 Q2 was 96.81 Million USD , down -6.74% from previous quarter.
  • Neuronetics, Inc. reported annual total assets of 116.88 Million USD in 2022, down -17.23% from previous year.
  • Neuronetics, Inc. reported annual total assets of 141.22 Million USD in 2021, up 79.54% from previous year.
  • Neuronetics, Inc. reported quarterly total assets of 96.81 Million USD for 2024 Q2, down -6.74% from previous quarter.
  • Neuronetics, Inc. reported quarterly total assets of 92.98 Million USD for 2023 Q3, down -7.38% from previous quarter.

Annual Total Assets Chart of Neuronetics, Inc. (2023 - 2016)

Historical Annual Total Assets of Neuronetics, Inc. (2023 - 2016)

Year Total Assets Total Assets Growth
2023 115.83 Million USD -0.9%
2022 116.88 Million USD -17.23%
2021 141.22 Million USD 79.54%
2020 78.65 Million USD -21.47%
2019 100.16 Million USD -14.4%
2018 117.02 Million USD 200.53%
2017 38.93 Million USD 57.02%
2016 24.79 Million USD 0.0%

Peer Total Assets Comparison of Neuronetics, Inc.

Name Total Assets Total Assets Difference
Aclaris Therapeutics, Inc. 197.4 Million USD 41.323%
Applied DNA Sciences, Inc. 13.65 Million USD -748.481%
Aspira Women's Health Inc. 6.26 Million USD -1749.744%
Biodesix, Inc. 99.09 Million USD -16.888%
BioNexus Gene Lab Corp. 11.39 Million USD -916.08%
bioAffinity Technologies, Inc. 8.22 Million USD -1308.87%
bioAffinity Technologies, Inc. 8.22 Million USD -1308.87%
Bionano Genomics, Inc. 214.4 Million USD 45.975%
CareDx, Inc 484.61 Million USD 76.098%
Check-Cap Ltd. 25.01 Million USD -363.009%
Castle Biosciences, Inc. 477.81 Million USD 75.758%
DarioHealth Corp. 96.38 Million USD -20.17%
Exact Sciences Corporation 6.47 Billion USD 98.21%
Fulgent Genetics, Inc. 1.27 Billion USD 90.902%
Guardant Health, Inc. 1.78 Billion USD 93.516%
ICON Public Limited Company 16.98 Billion USD 99.318%
IDEXX Laboratories, Inc. 3.25 Billion USD 96.447%
Illumina, Inc. 10.11 Billion USD 98.854%
Intelligent Bio Solutions Inc. 13.77 Million USD -740.643%
iSpecimen Inc. 15.81 Million USD -632.221%
Standard BioTools Inc. 323.06 Million USD 64.146%
MDxHealth SA 129.13 Million USD 10.3%
23andMe Holding Co. 395.16 Million USD 70.688%
Medpace Holdings, Inc. 1.65 Billion USD 93.009%
Myriad Genetics, Inc. 1.19 Billion USD 90.337%
Mainz Biomed B.V. 15.4 Million USD -651.709%
ENDRA Life Sciences Inc. 6.75 Million USD -1614.961%
NeoGenomics, Inc. 1.68 Billion USD 93.11%
Neogen Corporation 4.58 Billion USD 97.473%
Inotiv, Inc. 856.53 Million USD 86.477%
Natera, Inc. 1.45 Billion USD 92.051%
OpGen, Inc. 1.88 Million USD -6053.78%
OPKO Health, Inc. 2.01 Billion USD 94.242%
Psychemedics Corporation 13.27 Million USD -772.879%
Prenetics Global Limited 254.17 Million USD 54.428%
Prenetics Global Limited 254.17 Million USD 54.428%
Precipio, Inc. 18.1 Million USD -539.915%
Personalis, Inc. 225.09 Million USD 48.542%
RadNet, Inc. 2.88 Billion USD 95.987%
Sera Prognostics, Inc. 95.44 Million USD -21.364%
Sotera Health Company 3.13 Billion USD 96.3%
Star Equity Holdings, Inc. 86.97 Million USD -33.179%
Star Equity Holdings, Inc. 86.97 Million USD -33.179%
Trinity Biotech plc 59.43 Million USD -94.887%
T2 Biosystems, Inc. 34.79 Million USD -232.876%
Twist Bioscience Corporation 776.4 Million USD 85.081%
Exagen Inc. 56.94 Million USD -103.412%